drugset / Trial / NCT00195793

A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

NCT00195793

Phase 3 Completed 174 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate the effects of adding Tricor 145 mg to once daily atorvastatin 20 mg on CHD lipid laboratory parameters.

Timeline

Start
2004-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown
Subject Fenofibrate Small molecule 145 mg
Background Atorvastatin Small molecule 20 mg

Indications